Type 2 Diabetes
Discussed as a significant health risk identified through genome sequencing, which Dr. Snyder personally experienced, highlighting the importance of monitoring and personalized medicine.
Common Themes
Videos Mentioning Type 2 Diabetes

#140 - Gerald Shulman, MD, PhD: Insulin resistance—molecular mechanisms and clinical implications
Peter Attia MD
A pathological condition characterized by insulin resistance, hyperinsulinemia, and impaired glucose disposal, leading to widespread chronic diseases.

Health & Longevity: A Conversation with Peter Attia (Episode #328)
Sam Harris
A metabolic disorder characterized by high blood glucose levels, linked to increased risk of various chronic diseases.

#162 - Sarah Hallberg, D.O., M.S.: Treating metabolic disease, & a personal journey through cancer
Peter Attia MD
A chronic progressive disease that Dr. Hallberg became passionate about managing through unconventional, non-standard treatments.

Q&A on Zone 2 Exercise with Peter Attia, M.D.
Peter Attia MD
Mentioned as a condition that represents a failure of glucose disposal, contrasting with general age-related decline in glucose handling.

Daphne Koller: Biomedicine and Machine Learning | Lex Fridman Podcast #93
Lex Fridman
A metabolic disorder discussed as having some validated mechanisms but also many unknown factors.

#66 – Vamsi Mootha, MD: Aging, T2D, cancer, dementia, Parkinson’s—do all roads lead to mitochondria?
Peter Attia MD
A disease associated with reduced mitochondrial number and activity in skeletal muscle, with ongoing research into the causal link and its relationship to mitochondrial health.

255-Latest therapeutics in CVD, APOE’s role in Alzheimer’s disease, familial hypercholesterolemia
Peter Attia MD
A metabolic disease that a new CETP inhibitor might also help treat.

252 ‒ Latest insights on Alzheimer’s disease, cancer, exercise, nutrition, and fasting
Peter Attia MD
A condition strongly linked to Alzheimer's disease, with 50-80% of AD patients also having Type 2 Diabetes; suggested to increase AD risk through vascular dysfunction and blood-brain barrier permeability.

Dave Ricks, CEO of Eli Lilly | The All-In Interview
All-In Podcast
A primary chronic health condition linked to obesity, discussed as a major epidemic with severe health implications.
![ApoB, LDL-C, Lp(a), and insulin as risk factors for cardiovascular disease [AMA 43 sneak peek]](https://i.ytimg.com/vi/MAw4KMoBTPo/maxresdefault.jpg)
ApoB, LDL-C, Lp(a), and insulin as risk factors for cardiovascular disease [AMA 43 sneak peek]
Peter Attia MD
A metabolic disorder characterized by elevated blood glucose levels, strongly linked to hyperinsulinemia and increased cardiovascular risk.

Dr. Michael Snyder on Continuous Glucose Monitoring and Deep Profiling for Personalized Medicine
FoundMyFitness
Discussed as a significant health risk identified through genome sequencing, which Dr. Snyder personally experienced, highlighting the importance of monitoring and personalized medicine.
![Pros and cons of GLP-1 weight loss drugs and metformin as a geroprotective agent [AMA 45 sneak peek]](https://i.ytimg.com/vi/GCCHOBLTiCk/maxresdefault.jpg)
Pros and cons of GLP-1 weight loss drugs and metformin as a geroprotective agent [AMA 45 sneak peek]
Peter Attia MD
A metabolic disorder characterized by high blood glucose levels due to insulin resistance.

Dr. Matt Walker: The Biology of Sleep & Your Unique Sleep Needs | Huberman Lab Guest Series
Andrew Huberman
A metabolic disorder whose risk can significantly increase due to insufficient sleep, particularly deep sleep.
![Fruits & vegetables — everything you need to know [AMA 36 Sneak Peek] | Peter Attia, M.D.](https://i.ytimg.com/vi/mO9zCmmN8Nw/maxresdefault.jpg)
Fruits & vegetables — everything you need to know [AMA 36 Sneak Peek] | Peter Attia, M.D.
Peter Attia MD
Discussed as a condition where restricting fruit intake may be necessary to improve metabolic health.